Seeking AlphaThu, 30 Apr 2026 18:36:27 GMTZenas: 'Strong Buy' On Obexelimab Enhancement And Expected SLE Data Q4 2026ZBIO+4.02%
The Motley FoolSat, 21 Mar 2026 18:03:19 GMTENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to WatchZBIO+4.02%